跳至主要内容
临床试验/DRKS00011140
DRKS00011140已完成不适用

Effects of NSAID and metamizole exposure in the 1st trimester of pregnancy - An observational cohort study series - NSAIDs and Metamizol during pregnancy

Pharmakovigilanzzentrum EmbryonaltoxikologieCharité-Universitätsmedizin0 个研究点目标入组 7,184 人开始时间: 2016年10月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
7,184

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
Female

入选标准

  • Prospectively ascertained pregnancies, i.e. neither the outcome of pregnancy nor results of prenatal diagnostics are primarily known, but are ascertained at a later stage

排除标准

  • Exclusion of cases with maternal malignancies or maternal exposure considered as potent teratogens or fetotoxicants: i.e. acenocoumarol, ACE-inhibitors and ARBs (AT1-Antagonists), carbamazepine, lenalidomide, methotrexate, mycophenolate, phenobarbital, phenprocoumon, phenytoin, retinoids (acitretin, adapalen, isotretinoin, tazaroten, tretinoin), thalidomide, topimarat, valproic acid, warfarin.

研究者

发起方
Pharmakovigilanzzentrum EmbryonaltoxikologieCharité-Universitätsmedizin

相似试验

Effects of NSAID and metamizole exposure in the 1st... | 临床试验